Utah Medical Products price to free cash flow UTMD
Market value divided by free cash flow over the last twelve months, since 2020.
- Today, Oct 23, 2026
- 20.6×
- 6-year median
- 15.1×
- Against its 6-year history
- 99th
- percentile: 0 is its lowest day, 100 its highest
- 6-year range
- 10.9× to 20.7×
- Peer median
- 11.0×
Utah Medical Products' price to free cash flow is 20.6× as of Oct 23, 2026.
That is above its 6-year median of 15.1×, higher than on 99% of days in the last 6 years.
Over that time it ranged from 10.9× in Apr 2024 to 20.7× in Oct 2026.
The median for 10 medical instruments and supplies stocks of a similar size is 11.0×.
Price to free cash flow over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 20.6× | 13.0× | 20.7× |
| 2025 | 13.1× | 11.4× | 14.7× |
| 2024 | 12.4× | 10.9× | 13.8× |
| 2023 | 13.9× | 12.5× | 18.5× |
| 2022 | 18.8× | 14.8× | 18.8× |
| 2021 | 16.9× | 15.2× | 20.3× |
| 2020 | 16.2× | 14.1× | 17.6× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Utah Medical Products' size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| UTMDUtah Medical Products | 20.6× |
| INFUInfuSystem | 12.1× |
| PDEXPro DEX | 29.5× |
| EMBCEmbecta | 2.3× |
| TCMDTactile Systems Technology | 20.0× |
| MDXGMimedx | n/m |
| KEQUKewaunee Scientific | 8.7× |
| MOVMovado | 9.8× |
| APTAlpha Pro Tech | 9.7× |
| IRMDIradimed | 43.7× |
| STAAStaar Surgical | n/m |
| Peer median | 11.0× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on Utah Medical Products
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.